Paradox in Risk of Liver Disease: Presented at EACS (Hep C Chronic Fatigue)

Paradox in Risk of Liver Disease: Presented at EACS
DG News - Dec 12, 2005... HAART Based on Protease Inhibitors Is Associated with Lower Liver Fibrosis Progression among HIV Infected Patients with Chronic Hepatitis C. Abstract PS7/5. Is ...

Human Genome Sciences Announces Decision to Spin Off CoGenesys ...
PR Newswire (press release), NY - Dec 13, 2005... of systemic lupus erythematosus (SLE) and rheumatoid arthritis; Albuferon(TM) (albumin- interferon-alpha) for the treatment of chronic hepatitis C; and HGS ...

FDA Approvals: RPS Adeno Detector, Elecsys NT-proBNP Test, TBA ...
Medscape (subscription) - Jan 6, 2006... hepatitis, liver sclerosis, and liver cancer; monitoring of therapeutic efficacy in patients receiving interferon for chronic hepatitis C virus infection, and ...

Higher doses of pegylated interferon or ribavirin improve ...
Aidsmap, UK - Dec 8, 2005... Weight-based ribavirin dosing (WBD) increases sustained viral response (SVR) in patients with chronic hepatitis C (CHC): final results of the WIN-R study, a US ...

Hepatitis C patients to burden NHS
Daily Mail - UK, UK - Dec 13, 2005... Dr Helen Harris, a hepatitis C expert at the HPA, said: "Most individuals with chronic hepatitis C infection can be successfully treated, but the success of ...